Controlled & Modified Drug Release Summit

December 1-3, 2020 | USA

By attending the unique Controlled & Modified Drug Release Summit, you will learn directly from 50+ of industry’s leading experts and hear multiple unique case study sessions and take-home examples to enhance your product pipeline. Gather insights into the latest technologies and methods in improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.

Spotlight

A new way of thinking and working has evolved for the discovery of therapeutic antibodies. Until recently, large numbers of antibodies were generated, only for a relatively small fraction to be sampled and engineered for further lead generation.


OTHER PAST CONFERENCES

1st EuroAfrica Conference Cairo

February 9-13, 2023 | USA

EuroAfrica organising committee is honoured to announce the first edition of EuroAfrica organised in collaboration with our colleagues from the Egyptian Society of Critical Care and Emergency Medicine (ESCCEM).

33rd Annual European Pharma Congress

March 12-14, 2023 | Germany

The most anticipated Pharma event in the world and you're invited to attend 33rd Annual European Pharma Congress scheduled during March 13-14, 2023 at Frankfurt, Germany.

International Conference on Science, Health and Medicine (ICSHM)

January 1-2, 2023 | UAE

1420th International Conference on Science, Health and Medicine is a prestigious event organized with a motivation to provide an excellent international platform for the academicians, researchers, engineers, industrial participants and budding students around the world to SHARE their research findings with the global experts.

8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

February 8-9, 2023 | USA

MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.